Nuvectis Pharma NVCT Stock
Nuvectis Pharma Price Chart
Nuvectis Pharma NVCT Financial and Trading Overview
| Nuvectis Pharma stock price | 18 USD |
| Previous Close | 13.82 USD |
| Open | 13.84 USD |
| Bid | 11.74 USD x 200 |
| Ask | 20.78 USD x 200 |
| Day's Range | 13.02 - 16.64 USD |
| 52 Week Range | 5.55 - 16.64 USD |
| Volume | 408.07K USD |
| Avg. Volume | 92.84K USD |
| Market Cap | 438.47M USD |
| Beta (5Y Monthly) | -0.072 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.4 USD |
NVCT Valuation Measures
| Enterprise Value | 413.34M USD |
| Trailing P/E | N/A |
| Forward P/E | -17.218752 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 30.839552 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Nuvectis Pharma Stock Price History
| Beta (5Y Monthly) | -0.072 |
| 52-Week Change | 107.14% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 16.64 USD |
| 52 Week Low | 5.55 USD |
| 50-Day Moving Average | 10.06 USD |
| 200-Day Moving Average | 8.04 USD |
NVCT Share Statistics
| Avg. Volume (3 month) | 92.84K USD |
| Avg. Daily Volume (10-Days) | 145.91K USD |
| Shares Outstanding | 26.53M |
| Float | 15.27M |
| Short Ratio | 13.28 |
| % Held by Insiders | 42.13% |
| % Held by Institutions | 18.22% |
| Shares Short | 1.58M |
| Short % of Float | 10.14% |
| Short % of Shares Outstanding | 5.95% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -63.60% |
| Return on Equity (ttm) | -154.43% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -29589000 USD |
| Diluted EPS (ttm) | -1.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 25.13M USD |
| Total Cash Per Share (mrq) | 0.95 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.272 |
| Book Value Per Share (mrq) | 0.536 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18346000 USD |
| Levered Free Cash Flow (ttm) | -9166250 USD |
Profile of Nuvectis Pharma
| Country | United States |
| State | NJ |
| City | Fort Lee |
| Address | 1 Bridge Plaza |
| ZIP | 07024 |
| Phone | 201 614 3150 |
| Website | https://www.nuvectis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Q&A For Nuvectis Pharma Stock
What is a current NVCT stock price?
Nuvectis Pharma NVCT stock price today per share is 18 USD.
How to purchase Nuvectis Pharma stock?
You can buy NVCT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nuvectis Pharma?
The stock symbol or ticker of Nuvectis Pharma is NVCT.
Which industry does the Nuvectis Pharma company belong to?
The Nuvectis Pharma industry is Biotechnology.
How many shares does Nuvectis Pharma have in circulation?
The max supply of Nuvectis Pharma shares is 26.53M.
What is Nuvectis Pharma Price to Earnings Ratio (PE Ratio)?
Nuvectis Pharma PE Ratio is now.
What was Nuvectis Pharma earnings per share over the trailing 12 months (TTM)?
Nuvectis Pharma EPS is -1.31 USD over the trailing 12 months.
Which sector does the Nuvectis Pharma company belong to?
The Nuvectis Pharma sector is Healthcare.
Nuvectis Pharma NVCT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25642.83 USD — |
+0.22
|
2.12B USD — | 25577.63 USD — | 25749.06 USD — | — - | 2.12B USD — |
|
US Tech Health Care
IXHC
US
|
1204.58 USD — |
+1.68
|
— — | 1192.12 USD — | 1205.34 USD — | — - | — — |
- {{ link.label }} {{link}}